BSE Live
Nov 27, 16:01Prev. Close
132.40
Open Price
152.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 27, 15:57Prev. Close
132.58
Open Price
149.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
147.09 (3549)
| Key Financial Ratios of Indo US Bio-Tech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 8.12 | 4.11 | 7.51 | 8.56 | 8.40 | |
| Diluted EPS (Rs.) | 8.12 | 4.11 | 7.51 | 8.56 | 8.40 | |
| Cash EPS (Rs.) | 8.66 | 4.51 | 8.05 | 6.19 | 8.84 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 39.16 | 31.29 | 54.35 | 42.41 | 35.50 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 39.16 | 31.29 | 54.35 | 42.41 | 35.50 | |
| Dividend / Share(Rs.) | 0.25 | 0.00 | 0.00 | 0.25 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 51.78 | 36.32 | 61.58 | 54.60 | 66.06 | |
| PBDIT/Share (Rs.) | 9.53 | 5.54 | 9.37 | 7.73 | 9.13 | |
| PBIT/Share (Rs.) | 8.99 | 5.14 | 8.55 | 7.27 | 8.72 | |
| PBT/Share (Rs.) | 8.24 | 4.39 | 7.37 | 5.99 | 6.80 | |
| Net Profit/Share (Rs.) | 8.11 | 4.11 | 7.22 | 5.71 | 8.40 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 18.40 | 15.25 | 15.21 | 14.16 | 13.82 | |
| PBIT Margin (%) | 17.35 | 14.16 | 13.88 | 13.31 | 13.20 | |
| PBT Margin (%) | 15.91 | 12.08 | 11.96 | 10.96 | 10.29 | |
| Net Profit Margin (%) | 15.66 | 11.32 | 11.72 | 10.46 | 12.71 | |
| Return on Networth / Equity (%) | 20.71 | 13.15 | 13.28 | 13.47 | 23.66 | |
| Return on Capital Employed (%) | 22.10 | 15.39 | 14.99 | 15.37 | 20.61 | |
| Return on Assets (%) | 16.62 | 9.77 | 10.42 | 9.42 | 11.67 | |
| Total Debt/Equity (X) | 0.19 | 0.23 | 0.21 | 0.32 | 0.49 | |
| Asset Turnover Ratio (%) | 1.14 | 0.95 | 0.99 | 1.01 | 91.77 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.31 | 4.19 | 4.87 | 3.83 | 2.12 | |
| Quick Ratio (X) | 0.98 | 1.22 | 2.68 | 1.92 | 1.46 | |
| Inventory Turnover Ratio (X) | 1.70 | 0.00 | 0.00 | 0.00 | 3.37 | |
| Dividend Payout Ratio (NP) (%) | 3.19 | 0.00 | 0.00 | 2.89 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 2.99 | 0.00 | 0.00 | 2.67 | 0.00 | |
| Earnings Retention Ratio (%) | 96.81 | 0.00 | 0.00 | 97.11 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 97.01 | 0.00 | 0.00 | 97.33 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 309.85 | 458.28 | 224.46 | 74.33 | 30.11 | |
| EV/Net Operating Revenue (X) | 2.98 | 6.29 | 3.64 | 1.48 | 0.75 | |
| EV/EBITDA (X) | 16.21 | 41.23 | 23.89 | 10.49 | 5.43 | |
| MarketCap/Net Operating Revenue (X) | 2.84 | 6.11 | 3.45 | 1.24 | 0.49 | |
| Retention Ratios (%) | 96.80 | 0.00 | 0.00 | 97.10 | 0.00 | |
| Price/BV (X) | 3.76 | 7.09 | 3.91 | 1.59 | 0.92 | |
| Price/Net Operating Revenue | 2.84 | 6.11 | 3.45 | 1.24 | 0.49 | |
| Earnings Yield | 0.06 | 0.02 | 0.03 | 0.08 | 0.26 |
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017